Camp4 Therapeutics Corp (CAMP) Institutional Ownership

Ownership Summary

Camp4 Therapeutics Corp (NASDAQ:CAMP) showed up in the 13F filings of 41 institutional investors as of December 2025.

• These investors held 140.2% of outstanding shares in December 2025, up from 103.4% in September 2025.
• Their total shares held in CAMP increased 38.79% from the prior quarter, while the number of investors in Camp4 Therapeutics increased 7.89% year over year.
• Of these 41 holders, 24 added to their stakes in Camp4 Therapeutics, 10 trimmed positions, and 7 made no changes.
• The aggregate institutional position in Camp4 Therapeutics amounted to 38.25Mn shares as of December 2025, up by 10.69Mn shares quarter on quarter, and up 25.33Mn shares year over year.
• As of December 31, 2025, the biggest holder of Camp4 Therapeutics is Janus Henderson Group Plc at 6.31Mn shares, representing 23.13% of shares outstanding.
• Top purchasers of CAMP stock for the quarter ending December 2025 included BALYASNY ASSET MANAGEMENT L.P. (2.44Mn), Trails Edge Capital Partners, LP (1.98Mn), FMR LLC (1.89Mn), Janus Henderson Group Plc (1.67Mn), VANGUARD GROUP INC (1.36Mn).
• The biggest sellers of Camp4 Therapeutics for the quarter ending December 2025 included Enavate Sciences GP, LLC (749.98K), MILLENNIUM MANAGEMENT LLC (84.97K), Tower Research Capital LLC (TRC) (5.24K), TWO SIGMA INVESTMENTS, LP (2.84K), Mariner, LLC (1.93K).
• Per Business Quant, the top 10 investors in CAMP for the quarter ending December 2025 include Janus Henderson Group Plc (6.31Mn), 5AM Venture Management, LLC (5.87Mn), FMR LLC (4.92Mn), Vivo Capital, LLC (4.25Mn), Enavate Sciences GP, LLC (3.04Mn), BALYASNY ASSET MANAGEMENT L.P. (2.44Mn), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.18Mn), a16z Capital Management, L.L.C. (2.13Mn), Trails Edge Capital Partners, LP (1.98Mn), VANGUARD GROUP INC (1.67Mn).